Viewing StudyNCT00362700



Ignite Creation Date: 2024-05-05 @ 4:59 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00362700
Status: TERMINATED
Last Update Posted: 2017-02-01
First Post: 2006-08-08

Brief Title: Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201
Sponsor: Bukwang Pharmaceutical
Organization: Bukwang Pharmaceutical

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-07
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2005-10
Completion Date Type: None
First Submit Date: 2006-08-08
First Submit QC Date: August 8 2006
Study First Post Date: 2006-08-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-01-30
Last Update Post Date: 2017-02-01
Last Update Post Date Type: ESTIMATED